Establishment Labs Holdings (ESTA) Share-based Compensation (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Share-based Compensation of $7.9 million for Q4 2025, down 43.9% year-over-year from $14.0 million in Q4 2024, and up 480.95% quarter-over-quarter from -$2.1 million in Q3 2025.
Establishment Labs Holdings (ESTA) Share-based Compensation (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $7.9 million for Q4 2025.
- In Q4 2025, Share-based Compensation fell 43.9% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $9.0 million (down 46.28% YoY), while the FY2025 annual figure was $11.4 million, down 20.75% from the prior year.
- Share-based Compensation for Q4 2025 stood at $7.9 million, up from -$2.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $14.0 million in Q4 2024, with the low at -$10.1 million in Q4 2022.
- The 5-year median for Share-based Compensation is $2.1 million (2021), against an average of $2.5 million.
- The sharpest annual moves came in 2021 and 2022: Share-based Compensation slumped 12107.14% in 2021, then soared 77576.92% in 2022.
- Establishment Labs Holdings' Share-based Compensation stood at $10.3 million in 2021, then plunged by 197.86% to -$10.1 million in 2022, then surged by 134.18% to $3.5 million in 2023, then soared by 305.97% to $14.0 million in 2024, then sank by 43.9% to $7.9 million in 2025.
- Business Quant data shows ESTA's Share-based Compensation at $7.9 million in Q4 2025, -$2.1 million in Q3 2025, and $3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.23 Mn |
| Jun 30, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 7.86 Mn |
| Dec 31, 2025 | 7.86 Mn |
| Sep 30, 2025 | -2.06 Mn |
| Sep 30, 2025 | -2.06 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Dec 31, 2024 | 14.01 Mn |
| Dec 31, 2024 | 14.01 Mn |
| Sep 30, 2024 | 87,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |